BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in shares of Tilray Inc (NASDAQ:TLRY) by 6.1% in the third quarter, Holdings Channel.com reports. The firm owned 910,203 shares of the company’s stock after acquiring an additional 51,939 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Tilray were worth $10,293,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Tilray by 230.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,720,811 shares of the company’s stock worth $31,112,000 after buying an additional 1,200,779 shares during the last quarter. Bank of Montreal Can lifted its stake in Tilray by 738.2% in the 2nd quarter. Bank of Montreal Can now owns 1,312,719 shares of the company’s stock valued at $28,880,000 after purchasing an additional 1,156,112 shares during the last quarter. Public Sector Pension Investment Board acquired a new stake in Tilray in the 2nd quarter valued at about $19,950,000. California Public Employees Retirement System acquired a new stake in Tilray in the 3rd quarter valued at about $10,018,000. Finally, Dimensional Fund Advisors LP acquired a new stake in Tilray in the 2nd quarter valued at about $10,719,000. Hedge funds and other institutional investors own 12.09% of the company’s stock.
Several equities research analysts recently issued reports on the stock. MKM Partners cut their target price on shares of Tilray from $10.00 to $8.00 and set a “neutral” rating for the company in a research note on Tuesday, January 11th. Jefferies Financial Group reiterated a “buy” rating on shares of Tilray in a research note on Wednesday, October 20th. cut their price objective on shares of Tilray from $17.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, October 8th. Barclays assumed coverage on shares of Tilray in a research report on Thursday, November 18th. They set an “underweight” rating and a $10.00 price objective for the company. Finally, Cantor Fitzgerald cut their price objective on shares of Tilray from $11.80 to $7.40 and set a “neutral” rating for the company in a research report on Friday, January 7th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $13.62.
Shares of TLRY opened at $5.96 on Tuesday. The firm’s 50 day moving average is $7.72 and its 200-day moving average is $10.74. The stock has a market capitalization of $2.78 billion, a PE ratio of -3.12 and a beta of 2.39. The company has a current ratio of 2.25, a quick ratio of 1.51 and a debt-to-equity ratio of 0.16. Tilray Inc has a 12 month low of $5.15 and a 12 month high of $67.00.
Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Monday, January 10th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.12. The business had revenue of $155.10 million for the quarter, compared to analysts’ expectations of $171.57 million. Tilray had a negative net margin of 66.64% and a negative return on equity of 2.57%. Tilray’s revenue for the quarter was up 19.8% compared to the same quarter last year. Equities research analysts predict that Tilray Inc will post -0.24 earnings per share for the current fiscal year.
Tilray Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
https://etfdailynews.com/news/british-columbia-investment-management-corp-purchases-51939-shares-of-tilray-inc-nasdaqtlry/